| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.10.5.672 |
| P698 | PubMed publication ID | 2144959 |
| P2093 | author name string | Loscalzo J | |
| P433 | issue | 5 | |
| P304 | page(s) | 672-679 | |
| P577 | publication date | 1990-09-01 | |
| P1433 | published in | Arteriosclerosis (Dallas, Tex.) | Q27709176 |
| P1476 | title | Lipoprotein(a). A unique risk factor for atherothrombotic disease | |
| P478 | volume | 10 |
| Q37231203 | A Case-Control Study of the Relationship Between SLC22A3-LPAL2-LPA Gene Cluster Polymorphism and Coronary Artery Disease in the Han Chinese Population |
| Q72214749 | A PvuII polymorphism of the low density lipoprotein receptor gene is not associated with plasma concentrations of low density lipoproteins including LP(a) |
| Q35750052 | A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians |
| Q53154011 | A unique pattern of apo(a) polymorphism in an isolated east Greenlandic Inuit (Eskimo) population. |
| Q52537418 | Acute Myocardial Infarction and the Role of Aspirin, Heparin, and Warfarin. |
| Q73466877 | An application of apo(a) isoforms for the clinical assessment of Lp(a) |
| Q72548842 | Arterial thrombosis: putative role of lipoprotein(a) |
| Q72881694 | Atherogenic lipids and lipoproteins in hemodialysis patients |
| Q43953838 | Blood pressure, serum lipids, and fatty acids in populations on a lake-fish diet or on a vegetarian diet in Tanzania |
| Q36315574 | Cholesterol Metabolism in CKD |
| Q77896418 | Clinical profiles of plain versus sustained-release niacin (Niaspan) and the physiologic rationale for nighttime dosing |
| Q47764135 | Current thinking in lipid lowering |
| Q68184073 | Differences in apolipoprotein (a) polymorphism in west Greenland Eskimos and Caucasian Danes |
| Q71969962 | Does Increased Lipoprotein (a) Impair the Effectiveness of Thrombolysis With Streptokinase? |
| Q71940610 | Effect of hypertriglyceridaemia on lipoprotein (a) serum concentrations |
| Q71814226 | Effect of sample storage on quantitation of lipoprotein(a) by an enzyme-linked immunosorbent assay |
| Q77896443 | Efficacy and safety of an extended-release niacin (Niaspan): a long-term study |
| Q46692474 | Elevated lipoprotein(a) levels in patients with acute myeloblastic leukaemia decrease after successful chemotherapeutic treatment |
| Q35197067 | Expressed hypervariable polymorphism of apolipoprotein (a). |
| Q35643684 | Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus. |
| Q36233246 | Hypercoagulability in Vascular Surgery Patients |
| Q48082560 | Is lipoprotein (a) protective of dementia? |
| Q41386341 | Lipid lowering: the case for identifying and treating the high-risk patient |
| Q34647728 | Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study |
| Q70506625 | Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents |
| Q42337264 | Lipoprotein(a) and its role in occlusive vascular disease |
| Q38690186 | Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium |
| Q40983126 | Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease |
| Q73409252 | Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis |
| Q21284797 | Lipoprotein(a) in cardiovascular diseases |
| Q44434972 | Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in Type 2 diabetic patients |
| Q35350215 | Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role |
| Q40568220 | Lipoprotein(a): new insights into an atherogenic lipoprotein |
| Q67546740 | Lp(a): a link between thrombosis and atherosclerosis |
| Q33984026 | Novel markers of peripheral arterial disease |
| Q60308237 | Observational study of the status of coronary risk biomarkers among Negritos with metabolic syndrome in the east coast of Malaysia |
| Q71129084 | Pathophysiology of coronary artery disease |
| Q40737304 | Physical activity and lipoprotein lipid disorders |
| Q41104987 | Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria |
| Q46825446 | Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome |
| Q31879006 | Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial |
| Q73318670 | Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men |
| Q68231218 | Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease |
| Q24792333 | Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects |
| Q78617653 | Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role? |
| Q35824074 | Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). Evidence for the dominant role of kringle 4(37). |
| Q50949178 | Risk factors for ischaemic heart disease in patients with dermatitis herpetiformis. |
| Q53853760 | Role of coronary risk factors in blood thrombogenicity and acute coronary syndromes |
| Q41071705 | Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins |
| Q35245419 | The Gordon Wilson Lecture. Plasma cholesterol: atherogenesis and mortality |
| Q34154477 | The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate |
| Q53643980 | Thrombophilic state in young patients with acute myocardial infarction. |
| Q34319737 | Trans-fatty acids, dangerous bonds for health? A background review paper of their use, consumption, health implications and regulation in France |
| Q40760251 | Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women |
| Q38127353 | Treating thrombus in the coronary arteries |
| Q24601964 | Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production |
| Q36721982 | Vessel Wall-Related Risk Factors in Acute Vascular Events |
Search more.